Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions ; volume:12 ; number:1 ; day:4 ; month:8 ; year:2020 ; pages:1-14 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (4.8.2020), 1-14, 12.2020
- Creator
-
Teitsdottir, Unnur D.
Jonsdottir, Maria K.
Lund, Sigrun H.
Darreh-Shori, Taher
Snaedal, Jon
Petersen, Petur H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00657-8
- URN
-
urn:nbn:de:101:1-2020092922574706580213
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Teitsdottir, Unnur D.
- Jonsdottir, Maria K.
- Lund, Sigrun H.
- Darreh-Shori, Taher
- Snaedal, Jon
- Petersen, Petur H.
- SpringerLink (Online service)
Other Objects (12)
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease